ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer

NCT02972060 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ODM-201
DRUG: ADT

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]